Does the use of Refago L lead to increased risk of fractures?
Nov 4, 2023
Does the use of Refago L lead to increased risk of fractures?
Multiple research studies conducted in adult individuals provide evidence that the utilization of Refago L as a treatment option may potentially lead to a heightened susceptibility to fractures associated with osteoporosis Fractures that commonly occur in relation to osteoporosis encompass those affecting the hip wrist or spine It has been observed that the risk of experiencing such fractures is significantly enhanced in patients who are subjected to high doses of this medication The term high dose pertains to scenarios where patients are prescribed multiple daily doses of Refago L or are engaged in longterm therapy that spans over a year or more The findings from these studies emphasize the importance of closely monitoring patients who are administered Refago L particularly those who fall under the category of high dose usage Special consideration should be given to individuals who are undergoing prolonged treatment as they appear to be at an elevated risk of developing osteoporosisassociated fractures within the hip wrist or spine It is crucial for healthcare professionals to carefully assess the benefits and risks of Refago L treatment in each patient taking into account their individual medical history and current bone health status By maintaining vigilant oversight and tailoring treatment plans accordingly the potential for osteoporosisrelated fractures can be mitigated thereby promoting the overall wellbeing and safety of patients receiving this particular medication
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹130₹260
₹237₹263
₹189₹210
₹144₹160
₹328₹365
₹146₹162
₹255₹283
₹111₹123
₹135₹150